Mission:
To develop innovative encapsulation technologies that improve the stability, accessibility, and effectiveness of biologics and future vaccine delivery systems.
Home Page
Advancing Biologic and Vaccine Delivery Through Innovative Microencapsulation Research
HASTE Research Ltd is a biotechnology research company focused on developing innovative microencapsulation technologies for biologics, controlled-release systems, and future vaccine delivery platforms. Through academic collaboration and translational research, we aim to bridge scientific discovery and real-world healthcare solutions.
Why HASTE Research?
- Research-led innovation
- Expertise in microencapsulation technologies
- Focus on biologic stabilisation and delivery
- Commitment to academic and industry collaboration
- Vision for next-generation healthcare technologies
Current Status
HASTE Research Ltd is currently focused on developing academic partnerships, establishing collaborative research projects, and generating proof-of-concept data in support of future translational biotechnology applications.
Founder Statement
HASTE Research Ltd was founded to translate expertise in microencapsulation and biomedical science into meaningful healthcare innovation. Through collaboration with universities, researchers, and industry partners, we aim to develop scientifically robust solutions that contribute to the future of biologic delivery technologies.
Collaborate with HASTE Research
About Us
About Us
HASTE Research Ltd was founded to explore innovative approaches to biologic stabilisation and delivery through advanced encapsulation technologies. Our work focuses on generating scientific evidence, building academic collaborations, and supporting the development of future healthcare solutions.
Vision:
To become a recognised biotechnology research organisation contributing to the advancement of next-generation drug and vaccine delivery technologies.
Research
Research Themes
11. Alginate-Based Microencapsulation
Development of biocompatible encapsulation systems for stabilisation and protection of sensitive biological materials.
22. Controlled Release Technologies
Optimisation of formulation and processing parameters to achieve predictable release profiles.
33. Mechanical and Structural Characterisation
Evaluation of capsule morphology, integrity, and performance using scientific characterisation techniques.
44. Future Vaccine Delivery Platforms
Long-term exploration of oral and inhaled delivery approaches designed to improve accessibility and patient compliance.
Founder
Founder Profile
Dr Chand Zahid Khan
Founder & Director
- PhD in Microencapsulation
- Biomedical Scientist
- Science Educator
- Biotechnology Researcher
Founder Statement:
HASTE Research Ltd was founded to translate expertise in microencapsulation and biomedical science into meaningful healthcare innovation. Through collaboration with universities, researchers, and industry partners, we aim to develop scientifically robust solutions that contribute to the future of biologic delivery technologies.
Partnerships
Collaboration Opportunities
HASTE Research Ltd is actively seeking:
- University research partnerships
- MSc projects
- PhD collaborations
- Innovation funding opportunities
- Industry collaborations
- Translational research partnerships
We welcome discussions with researchers, academic institutions, healthcare organisations, and innovation partners interested in collaborative research.
Planning
Research Roadmap
2026
- Establish university collaborations
- Develop MSc and PhD projects
- Generate proof-of-concept research data
2027–2028
- Publish research outputs
- Secure grant funding
- Expand collaborative research activities
Future
- Advance biologic delivery technologies
- Explore translational healthcare applications
- Support development of future vaccine delivery systems
Contact
Contact Page
Contact Form Categories:
- Research Collaboration
- MSc Project Enquiry
- PhD Project Enquiry
- Funding Opportunity
- General Enquiry